P01889 (HLAB_HUMAN) Homo sapiens (Human)

HLA class I histocompatibility antigen, B alpha chain UniProtKBInterProSTRINGInteractive Modelling

362 aa; Sequence (Fasta) ; 1 identical sequence: Homo sapiens: E5FQ95

Available Structures

218 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
Crystal structure of HLA-B*07:02 with R140Q mutant IDH2 peptide Heteromer
P48735; P61769;
K;NA;25-304
Assess
HLA class I micropolymorphisms determine peptide-HLA landscape and dictate differential HIV-1 escap… Heteromer
P03407; P61769;
26×EDO;GOL;25-301
Assess
HLA class I micropolymorphisms determine peptide-HLA landscape and dictate differential HIV-1 escap… Heteromer
P04585; P61769;
EDO;25-301
Assess
HLA class I micropolymorphisms determine peptide-HLA landscape and dictate differential HIV-1 escap… Heteromer
P61769; P69726;
12×EDO;SO4;GOL;25-301
Assess
HLA class I micropolymorphisms determine peptide-HLA landscape and dictate differential HIV-1 escap… Heteromer
P03407; P61769;
12×EDO;GOL;25-301
Assess
HLA B8 in complex with an Epstein Barr Virus determinant Heteromer
P12977; P61769;
CD;25-301
Assess
HLA class I micropolymorphisms determine peptide-HLA landscape and dictate differential HIV-1 escap… Heteromer
P04585; P61769;
EDO;GOL;SO4;25-301
Assess
The crystal structure of LC13 TcR in complex with HLAB8-EBV peptide complex Heteromer
P01848; P01850; P61769; Q3KST2;
25-301
Assess
DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B3501 DUE TO NONSTANDARD POSITIONING OF TH… Heteromer
P61769;
25-301
Assess
Crystal structure of an anaplastic lymphoma kinase-derived neuroblastoma tumor antigen bound to the… Heteromer
P61769; Q9UM73;
GOL;SO4;25-301
Assess
COMPLEX RECOGNITION OF THE SUPERTYPIC BW6-DETERMINANT ON HLA-B AND-C MOLECULES BY THE MONOCLONAL AN… Heteromer
P03204; P61769;
25-301
Assess
Crystal Structure of CF34 TCR in complex with HLA-B8/FLR Heteromer
P01850; P61769;
CD;CL;NA;25-301
Assess
Crystal structure of the RL42 TCR in complex with HLA-B8-FLR Heteromer
P01848; P61769; Q3KST2;
25-301
Assess
DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B3501 DUE TO NONSTANDARD POSITIONING OF TH… Heteromer
P61769;
25-301
Assess
HLA-B*2709 BOUND TO NONA-PEPTIDE M9 Heteromer
P61769;
GOL;25-300
Assess
Crystal structure of HLA-B*2709 complexed with the glucagon receptor (GR) peptide (residues 412-420) Heteromer
P47871; P61769;
GOL;25-300
Assess
Crystal Structure of HLA-B*18:01 in complex with NP338 influenza peptide Heteromer
P61769;
25-300
Assess
Crystal structure of a peptide-HLA complex Heteromer
P03206; P61769;
ACT;NA;25-300
Assess
Crystal Structure of HLA B*3508 in complex with a HCMV 8-mer peptide from the pp65 protein Heteromer
P18139; P61769;
25-300
Assess
Crystal Structure of HLA-B*37:01 in complex with NP338 influenza peptide Heteromer
P61769;
ACT;25-300
Assess
Crystal Structure of HLA-B*44:05 in complex with NP338 influenza peptide Heteromer
P61769;
ACT;25-300
Assess
Crystal Structure of HLA-B*2705-W60A in complex with LRN, a self-peptide Heteromer
P37268; P61769;
25-300
Assess
Crystal Structure of HLA B*0801 in complex with ELN_YYM, ELNRKMIYM Heteromer
P61769; Q9YRL8;
EDO;25-300
Assess
Crystal Structure of HLA B*0801 in complex with ELK_IYM, ELKRKMIYM Heteromer
P61769; Q9YRL3;
ACT;25-300
Assess
Crystal structure of hla-b*2705 complexed with the glucagon receptor (gr) peptide (residues 412-420) Heteromer
P47871; P61769;
GOL;NA;25-300
Assess
Crystal Structure of HLA-B8 in complex with ELR, an Influenza A virus peptide Heteromer
P61769;
25-300
Assess
HLA-B*1801 in complex with a self-peptide, DELEIKAY Heteromer
P61769;
ACT;25-300
Assess
Crystal structure of HLA-B*27:05 complexed with the self-peptide pVIPR Heteromer
P32241; P61769;
GOL;25-300
Assess
Crystal Structure of HLA-B*2703-P47G in complex with LRN, a self-peptide Heteromer
P37268; P61769;
25-300
Assess
CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE 1 RECEPTOR (V… Heteromer
P32241; P61769;
GOL;MN;25-300
Assess
Conformational Restraints and Flexibility of 14-Meric Peptides in Complex with HLA-B*3501 Heteromer
P61769;
25-300
Assess
HLA-B*18:01 in complex with Epstein-Barr virus BZLF1-derived peptide (residues 173-180) Heteromer
Q3KSS8;
ACT;25-300
Assess
Crystal structure of HLA-B*3508 presenting 13-mer EBV antigen LPEPLPQGQLTAY Heteromer
P61769;
25-300
Assess
Structure of HLA-B*40:02 in complex with the phosphorylated endogenous peptide REF(p)SKEPEL Heteromer
P61769; Q9NQS7;
EDO;25-300
Assess
Crystal Structure of HLA-B*2703 in complex with KK10, an HIV peptide Heteromer
P04585; P61769;
MG;25-300
Assess
Crystal Structure of HLA-B*2703 in complex with LRN, a self-peptide Heteromer
P37268; P61769;
25-300
Assess
Crystal Structure of HLA-B*37:01 in complex with NP338-L7S influenza peptide Heteromer
P61769;
25-300
Assess
Crystal Structure of HLA-B*37:01 in complex with NP338-V6L influenza peptide Heteromer
P61769;
25-300
Assess
crystal structure of HLA B*3508 LPEP-P9Ala, peptide mutant P9-ala Heteromer
P61769;
25-300
Assess
CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2)OF EPSTE… Heteromer
P13285; P61769;
GOL;25-300
Assess
Crystal Structure of HLA-B8 in complex with QIK, a CMV peptide Heteromer
P61769;
25-300
Assess
Crystal Structure of HLA-B*57:01 with an HIV peptide RKV Heteromer
P04578; P61771;
25-300
Assess
HLA class I micropolymorphisms determine peptide-HLA landscape and dictate differential HIV-1 escap… Heteromer
P04585; P61769;
11×EDO;GOL;25-300
Assess
Structure of a nested set of N-terminally extended MHC I-peptides provides novel insights into anti… Heteromer
P61769;
25-300
Assess
Crystal structure of HLA-B*3501 presenting 13-mer EBV antigen LPEPLPQGQLTAY Heteromer
P61769;
25-300
Assess
Crystal Structure of HLA B2705-KK10 Heteromer
P03366; P61769;
GOL;25-300
Assess
Crystal structure of the HLA-B8-A66-FLR, mutant A66 of the HLA B8 Heteromer
P61769; Q3KST2;
NA;25-300
Assess
Crystal structure of B*27:04 complex bound to the pVIPR peptide Heteromer
P32241; P61769;
GOL;CL;25-300
Assess
Crystal Structure of HLA B2705-KK10-L6M Heteromer
P03366; P61769;
TRS;25-300
Assess
Crystal Structure of HLA B*0801 in complex with ELR_MYM, ELRRKMMYM Heteromer
P03169; P61769;
ACT;25-300
Assess
Crystal Structure of HLA B*4402 in complex with EEYLKAWTF, a mimotope Heteromer
P61769;
25-300
Assess
Crystal Structure of HLA-B*4403 presenting 10mer EBV antigen Heteromer
P03204; P61769;
ACT;GOL;25-300
Assess
Crystal Structure of HLA-B7 in complex with TPR, a CMV peptide Heteromer
P61769;
IOD;NA;CL;PEG;ZN;25-300
Assess
Crystal Structure of HLA B*4402 in complex with HLA DPA*0201 peptide Heteromer
P61769; Q95HB9;
25-300
Assess
HLA-B*58:01 presenting LSSPVTKSW Heteromer
P61769;
25-300
Assess
crystal structure of HLA B*3508 LPEP-P7Ala, peptide mutant P7-ala Heteromer
P61769;
25-300
Assess
Crystal structure of a HLA-B*35:01-HPVG-A4 Heteromer
P61769; Q1HVF7;
ACT;25-300
Assess
Crystal structure of HLA-B35 in complex with a pepetide antigen Heteromer
P04585; P61769;
25-300
Assess
Crystal structure of an anaplastic lymphoma kinase-derived neuroblastoma tumor antigen bound to the… Heteromer
P61769;
25-300
Assess
Crystal Structure Of HLA-B*3501 Presenting an 11-Mer EBV Antigen EPLPQGQLTAY Heteromer
P03206; P61769;
25-300
Assess
A natural selected dimorphism in HLA B*44 alters self, peptide reportoire and T cell recognition. Heteromer
P61769; Q95HB9;
ACY;25-300
Assess
Crystal structure of HLA-B*3508 presenting EBV peptide EPLPQGQLTAY at 1.7A Heteromer
P61769;
25-300
Assess
Crystal structure of HLA-B*4402 in complex with the F7A mutant of a self-peptide derived from DPA*0… Heteromer
P61769; Q95HB9;
GOL;25-300
Assess
HLA-B*4405 complexed to the dominant self ligand EEFGRAYGF Heteromer
P61769; Q9TQB0;
25-300
Assess
Crystal Structure of HLA B*0801 in complex with HSKKKCDEL Heteromer
P61769; X2G898;
25-300
Assess
Crystal Structure of B*4402 presenting a 10mer EBV epitope Heteromer
P03204; P61769;
ACT;GOL;25-300
Assess
CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE (LMP2) OF EPST… Heteromer
P13285; P61769;
GOL;25-300
Assess
Crystal structure of HLA-B*2709 complexed with a variant of the latent membrane protein 2 peptide (… Heteromer
P61769;
GOL;TRS;MES;25-300
Assess
Crystal Structure of HLA B*3508 in complex with a HCMV 12-mer peptide from the pp65 protein Heteromer
P18139; P61769;
25-300
Assess
HLA-B*57:01 presenting TSTFEDVKILAF Heteromer
P61769; Q6YHU6;
GOL;ACT;25-300
Assess
Crystal Structures of HLA-B*1501 in Complex with Peptides from Human UbcH6 and Epstein-Barr Virus E… Heteromer
P51965; P61769;
SO4;URE;GOL;25-300
Assess
Crystal structure of HLA-B*0801.N80I Heteromer
P61769;
25-300
Assess
Crystal Structure of HLA B*3501 in complex with influenza NP418 epitope from 1934 strain Heteromer
P61769;
25-300
Assess
Crystal structure of the HLA-B8FLRGRAYVL, mutant G8V of the FLR peptide Heteromer
P61769; Q3KST2;
25-300
Assess
HLA-B*57:03 presenting LTVQVARVW Heteromer
P61769;
25-300
Assess
Crystal structure of a HLA-B*35:01-HPVG-D5 Heteromer
P61769; Q3KSS4;
25-300
Assess
HLA-B*57:01 presenting LTVQVARVW Heteromer
P61769;
25-300
Assess
Crystal structure of HLA-B*4402 in complex with the F3A mutant of a self-peptide derived from DPA*0… Heteromer
P61769; Q95HB9;
ACT;GOL;25-300
Assess
Crystal Structure of HLA B*3501 in complex with influenza NP418 epitope from 1972 strain Heteromer
P61769;
25-300
Assess
Crystal Structure of hla-b*2705 Complexed with the Citrullinated Vasoactive Intestinal Peptide Type… Heteromer
P32241; P61769;
25-300
Assess
The high resolution crystal structure of HLA-B*2709 in complex with a Cathepsin A signal sequence p… Heteromer
P10619; P61769;
GOL;25-300
Assess
Crystal Structure of HLA B*3501 in complex with influenza NP418 epitope from 1977 strain Heteromer
P61769;
25-300
Assess
HLA-B*58:03 presenting LTVQVARVY Heteromer
P61769;
25-300
Assess
The Immunogenicity of a Viral Cytotoxic T Cell Epitope is controlled by its MHC-bound Conformation Heteromer
P03206; P61769;
ACY;25-300
Assess
Structure of HLA-B*40:02 in complex with the endogenous peptide REFSKEPEL Heteromer
P61769; Q9NQS7;
25-300
Assess
Crystal Structure of HLA-B7 in complex with SPI, an influenza peptide Heteromer
P61769;
25-300
Assess
HLA-B*57:01 presenting GSFDYSGVHLW Heteromer
P61769;
25-300
Assess
Crystal structure of B*27:06 bound to the pVIPR peptide Heteromer
P32241; P61769;
GOL;25-300
Assess
Crystal Structure of HLA B*4405 in complex with EEYLKAWTF, a mimotope Heteromer
P61769;
25-300
Assess
The high resolution crystal structure of HLA-B*2705 in complex with a Cathepsin A signal sequence p… Heteromer
P10619; P61769;
GOL;25-300
Assess
crystal structure of HLA B*3508LPEP-P5Ala , peptide mutant P5-ala Heteromer
P61769;
25-300
Assess
Citrullination-dependent differential presentation of a self-peptide by HLA-B27 subtypes Heteromer
P32241; P61769;
GOL;25-300
Assess
Crystal Structure of a SARS Corona Virus Derived Peptide Bound to the Human Major Histocompatibilit… Heteromer
P61769;
PG4;EPE;25-300
Assess
HLA-B*57:01 presenting TSMSFVPRPW Heteromer
P61769;
25-300
Assess
HLA-B*44:03 in complex with Epstein-Barr virus BZLF1-derived peptide (residues 169-180) Heteromer
P61769; Q3KSS8;
GOL;ACT;25-300
Assess
HLA-B*57:01 presenting LTVQVARVY Heteromer
P61769;
25-300
Assess
Crystal Structure of HLA B*3501 in complex with influenza NP418 epitope from 1980 strain Heteromer
P61769;
25-300
Assess
Crystal Structure of C12C TCR-HLAB2705-KK10-L6M Heteromer
P03366; P61769;
SO4;25-300
Assess
HLA-B*2709 bound to deca-peptide s10R Heteromer
P61769;
GOL;25-300
Assess
Crystal structure of HLA-B*3501 presenting the human cytochrome P450 derived peptide, KPIVVLHGY Heteromer
P33260; P61769;
25-300
Assess
HLA-B*57:01 presenting LALLTGVRW Heteromer
P61769;
25-300
Assess
Crystal Structure of HLA B*4405 in complex with EEYLQAFTY a self peptide from the ABCD3 protein Heteromer
P61769;
PEG;25-300
Assess
Crystal structure of HLA-B*27:05 complexed with the self-peptide pVIPR and Copper Heteromer
P32241; P61769;
CU;GOL;25-300
Assess
Crystal structure of HLA-B*27:05 complexed with the self-peptide pVIPR measured at 295 K Heteromer
P32241; P61769;
25-300
Assess
Crystal structure of HLA-B*2705 complexed with a peptide derived from the human voltage-dependent c… Heteromer
P61769; Q01668;
GOL;25-300
Assess
crystal structure of HLA B*3508LPEP-P6Ala, peptide mutant P6-ala Heteromer
P61769;
25-300
Assess
Crystal structure of HLA-B*2709 complexed with the double citrullinated vasoactive intestinal pepti… Heteromer
P32241; P61769;
25-300
Assess
Crystal structure of HLA-B*27:05 complexed with the self-peptide pVIPR and Nickel Heteromer
P32241; P61769;
NI;GOL;25-300
Assess
Crystal Structure of HLA B*4402 in complex with EEYLQAFTY a self peptide from the ABCD3 protein Heteromer
P61769;
25-300
Assess
HLA-B*07:02 in complex with 229E-derived coronavirus nucleocapsid peptide N75-83 Heteromer
P15130; P61769;
ZN;NA;CL;K;BR;25-300
Assess
HLA-B*57:01 presenting LSSPVTKSW Heteromer
P61769;
25-300
Assess
The Immunogenicity of a Viral Cytotoxic T Cell Epitope is controlled by its MHC-bound Conformation Heteromer
P03206; P61769;
ACY;25-300
Assess
HLA-B*58:01 presenting LTVQVARVW Heteromer
P61769;
25-300
Assess
Crystal Structure of HLA B*3501 in complex with influenza NP418 epitope from 2009 H1N1 swine origin… Heteromer
P61769;
25-300
Assess
Crystal structure of HLA-B*0801.N80I.R82L.G83R Heteromer
P61769;
25-300
Assess
The structure of HLA-B*35:01 in complex with the peptide (RPQVPLRPMTY) Heteromer
P61769; Q9YYU8;
25-300
Assess
Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-… Heteromer
P61769; Q98Y46;
25-300
Assess
Crystal Structure of HLA B*3501 in complex with influenza NP418 epitope from 1918 strain Heteromer
P61769;
25-300
Assess
Crystal Structure of HLA B*4403 in complex with EEYLQAFTY a self peptide from the ABCD3 protein Heteromer
P61769;
25-300
Assess
Crystal Structure of the TK3 TCR in complex with HLA-B*3501/HPVG Heteromer
P03211; P61769;
SO4;25-300
Assess
MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTY FROM THE NEF PROTEIN (75-82) OF HIV1 Heteromer
P61769;
25-300
Assess
Crystal structure of HLA-B*5801 complex with HIV-1 gag derived peptide TW10 Heteromer
P03366; P61769;
25-300
Assess
HLA-B*57:01 presenting LSDSTARDVTW Heteromer
P61769;
25-300
Assess
ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYKL-INDEX… Heteromer
P61769;
25-300
Assess
HLA class I micropolymorphisms determine peptide-HLA landscape and dictate differential HIV-1 escap… Heteromer
P03407; P61769;
GOL;EDO;SO4;25-300
Assess
HLA class I micropolymorphisms determine peptide-HLA landscape and dictate differential HIV-1 escap… Heteromer
P03407; P61769;
GOL;EDO;SO4;25-300
Assess
Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-… Heteromer
P03466; P61769;
25-300
Assess
Crystal structure of HLA-B*2705 complexed with the double citrullinated vasoactive intestinal pepti… Heteromer
P32241; P61769;
25-300
Assess
ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYQL-7Q MU… Heteromer
P61769;
25-300
Assess
Crystal Structure of the TK3-Gln55His TCR in complex with HLA-B*3501/HPVG Heteromer
P03211; P61769;
SO4;25-300
Assess
Crystal structure of HLA-B*4402 in complex with the R5A mutant of a self-peptide derived from DPA*0… Heteromer
P61769; Q95HB9;
ACT;GOL;25-300
Assess
HLA-B*2705 bound to nona-peptide m9 Heteromer
P61769;
25-300
Assess
THE THREE-DIMENSIONAL STRUCTURE OF HLA-B27 AT 2.1 ANGSTROMS RESOLUTION SUGGESTS A GENERAL MECHANISM… Heteromer
P61769;
25-300
Assess
Crystal Structure of B*4405 presenting a 10mer EBV epitope Heteromer
P03204; P61769;
GOL;25-300
Assess
Crystal Structure Of HLA-B*2709 Complexed With the self-Peptide TIS from EGF-response factor 1 Heteromer
P47974; P61769;
GOL;25-300
Assess
Crystal structure of HLA-B5801, a protective HLA allele for HIV-1 infection Heteromer
P04591; P61769;
25-300
Assess
Crystal structure of HLA-B*57:01.I80N.L82R.R83G Heteromer
P01834; P61769;
25-300
Assess
Crystal structure of the 'restriction triad' mutant of HLA B*3508, beta-2-microglobulin and EBV pep… Heteromer
P03206; P61769;
ACY;GOL;PEG;25-300
Assess
ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGRKKYKL-3R MU… Heteromer
P61769;
25-300
Assess
Nonstandard peptide binding of HLA-B*5101 complexed with HIV immunodominant epitope KM1(LPPVVAKEI) Heteromer
P24740; P61769;
25-300
Assess
Crystal structure of HLA-B*2709 complexed with the vasoactive intestinal peptide type 1 receptor (V… Heteromer
P32241; P61769;
GOL;MN;25-300
Assess
ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKRYKL-5R MU… Heteromer
P61769;
25-300
Assess
Crystal Structure Of HLA-B*2705 Complexed With the self-Peptide TIS from EGF-response factor 1 Heteromer
P47974; P61769;
GOL;25-300
Assess
MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE TPYDINQML FROM GAG PROTEIN OF HIV2 Heteromer
P61769;
25-300
Assess
crystal structure of HLA B*3508 LPEP-P10Ala, peptide mutant P10-ala Heteromer
P61769;
25-300
Assess
Crystal Structure of HLA B*4403 in complex with EEYLKAWTF, a mimotope Heteromer
P61769;
25-300
Assess
Crystal Structures of HLA-B*1501 in Complex with Peptides from Human UbcH6 and Epstein-Barr Virus E… Heteromer
P12977; P61769;
PG4;URE;GOL;25-300
Assess
Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-… Heteromer
P03204; P61769;
25-300
Assess
ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8-HIV-1 GAG PEPTIDE (GGKKKYRL-7R MU… Heteromer
P61769;
25-300
Assess
MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) FROM THE MALARIA PARASITE P. FAL… Heteromer
P61769;
25-300
Assess
Crystal Structure of C12C TCR-HA B2705-KK10 Heteromer
P03366; P61769;
25-300
Assess
Crystal structure of HLA, B*4403, and peptide EEPTVIKKY Heteromer
P61769; Q9Y5X3;
25-300
Assess
Crystal structure of HLA-B*4402 in complex with the F3A/R5A double mutant of a self-peptide derived… Heteromer
P61769; Q95HB9;
ACT;25-300
Assess
Crystal structure of HLA-B*27:09 complexed with the self-peptide pVIPR and Copper Heteromer
P32241; P61769;
CU;25-300
Assess
Crystal Structure of SB27 TCR in complex with HLA-B*3508-13mer peptide Heteromer
P01848; P01850; P03206; P61769;
IOD;25-300
Assess
Crystal structure of HLA-B5801, a protective HLA allele for HIV-1 infection Heteromer
P04585; P61769;
25-300
Assess
Crystal Structure of the LC13 TCR in complex with HLA B*4405 bound to EEYLKAWTF a mimotope Heteromer
P01848; P01850; P61769;
25-300
Assess
Crystal structure of HLA-B*4402 in complex with the R5A/F7A double mutant of a self-peptide derived… Heteromer
P61769; Q95HB9;
GOL;25-300
Assess
Crystal Structure of the TK3-Gln55Ala TCR in complex with HLA-B*3501/HPVG Heteromer
P03211; P61769;
SO4;25-300
Assess
Crystal Structure of the LC13 TCR in complex with HLA B*4405 bound to EEYLQAFTY a self peptide from… Heteromer
P01848; P01850; P61769;
25-300
Assess
Crystal structure of ELS4 TCR bound to HLA-B*3501 presenting EBV peptide EPLPQGQLTAY at 1.7A Heteromer
P01848; P01850; P03206; P61769;
25-300
Assess
Crystal structure of pHLA-B35 in complex with TU55 T cell receptor Heteromer
P04585; P61769;
GOL;25-300
Assess
Crystal structure of HLA-B*5701 complex with HIV-1 gag derived peptide TW10 Heteromer
P03366; P61769;
25-300
Assess
HLA-B*07:02 in complex with SARS-CoV-2 nucleocapsid peptide N105-113 Heteromer
P0DTC9; P61769;
CL;25-300
Assess
Crystal structure of HLA-B5801, a protective HLA allele for HIV-1 infection Heteromer
P04591; P61769;
25-300
Assess
Crystal Structure of HLA B*0801 in complex with HSKKKCDEL and DD31 TCR Heteromer
P61769; X2G898;
IOD;NA;25-300
Assess
Crystal structure of HLA-B*07:02 with R140Q mutant IDH2 peptide in complex with Fab Heteromer
P48735; P61769;
PEG;NHE;SO4;25-300
Assess
T cell response to a HIV reverse transcriptase epitope presented by the protective allele HLA-B*51:… Heteromer
K7N5M3; P01850; P61769; R4WL38;
25-300
Assess
Nonstandard peptide binding of HLA-B*5101 complexed with HIV immunodominant epitope KM2(TAFTIPSI) Heteromer
P12499; P61769;
25-300
Assess
Crystal Structure of EM2 TCR in complex with HLA-B*37:01-NP338 Heteromer
P61769;
25-300
Assess
Crystal Structure of HLA B*3501-IPS in complex with a Delta-Beta TCR, clone 12 TCR Heteromer
P18139; P61769;
25-300
Assess
Crystal Structure of SB27 TCR in complex with the 'restriction triad' mutant HLA-B*3508-13mer Heteromer
A0A5B9; P01848; P03206; P61769;
IOD;25-300
Assess
Crystal structure of HLA-B*5201 in complexed with HIV immunodominant epitope (TAFTIPSI) Heteromer
P12499; P61769;
25-300
Assess
Structure of HD14 TCR in complex with HLA-B7 presenting an EBV epitope Heteromer
P12977; P61769;
PEG;EDO;25-300
Assess
TCR589 in complex with HIV(Pol448-456)/HLA-B35 Heteromer
P04585; P61769;
NAG;ZN;NAG;25-300
Assess
Crystal Structure of the DM1 TCR in complex with HLA-B*4405 and decamer EBV antigen Heteromer
P01848; P03204; P61769;
25-300
Assess
Structure of a nested set of N-terminally extended MHC I-peptides provides novel insights into anti… Heteromer
P61769;
25-299
Assess
Crystal Structure of HLA-B*57:01 with a modified HIV peptide RKV-Kyn Heteromer
P04578; P61769;
ACT;25-299
Assess
Structure of a nested set of N-terminally extended MHC I-peptides provides novel insights into anti… Heteromer
P61769;
25-299
Assess
Crystal structure of HLA-B*07:02 in complex with an NY-ESO-1 peptide Heteromer
P61769; P78358;
25-299
Assess
Structure of a nested set of N-terminally extended MHC I-peptides provide novel insights into antig… Heteromer
P61769;
25-299
Assess
HLA-B*57:01-RVAQLENVYI in complex with abacavir Heteromer
P61769; P62318;
1KX;SO4;26-300
Assess
Structures of Three HIV-1 HLA-B5703-Peptide Complexes and Identification of Related HLAs Potentiall… Heteromer
P61769; Q70A61;
25-299
Assess
Structure of a nested set of N-terminally extended MHC I-peptides provide novel insights into antig… Heteromer
P61769;
25-299
Assess
HLA-B*57:01 presenting TSTTSVASSW Heteromer
P61769; Q14679;
GOL;25-299
Assess
Crystal Structure of HLA-B0702-RFL9 Heteromer
P12478; P61769;
25-299
Assess
Crystal Structure of HLA-B7 with the HCMV pp65 peptide RPHERNGFTVL Heteromer
P61769; Q6SW59;
NI;GOL;25-299
Assess
KIR3DL1 in complex with HLA-B*5701 Heteromer
P01834; P43629; P61769;
NAG;25-299
Assess
Crystal structure of HLA-B*57:01.I80N Heteromer
P01834; P61769;
26-300
Assess
Crystal Structure of HLA-B0702-RL9 Heteromer
P12478; P61769;
25-299
Assess
TCR55 in complex with HIV(Pol448-456)/HLA-B35 Heteromer
P04585; P61769;
EDO;SO4;26-300
Assess
HLA-B*57:01 presenting SSTRGISQLW Heteromer
P61769; Q96HA1;
GOL;25-299
Assess
HLA-B*57:01-LTTKLTNTNI in complex with abacavir Heteromer
P00403; P61769;
1KX;26-300
Assess
Human leukocyte antigen B*07:02 in complex with SARS-CoV2 epitope IPRRNVATL Heteromer
P0DTD1; P61769;
25-299
Assess
HLA-B*57:01 complexed to pep-V and Abacavir Heteromer
P61769;
1KX;CL;26-300
Assess
KIR3DL1 in complex with HLA-B*57:01-TW10 Heteromer
P03366; P43629; P61769;
NAG;25-299
Assess
KIR3DL1 in complex with HLA-B*57:01.I80T Heteromer
P01834; P43629; P61769;
NAG;25-299
Assess
Structures of Three HIV-1 HLA-B5703-Peptide Complexes and Identification of Related HLAs Potentiall… Heteromer
P61769; Q70A61;
25-299
Assess
Crystal structure of the KFJ5 TCR-NY-ESO-1-HLA-B*07:02 complex Heteromer
P61769; P78358;
25-299
Assess
KIR3DL1 in complex with HLA-B*57:01 presenting TSNLQEQIGW Heteromer
P03366; P43629; P61769;
NAG;25-299
Assess
Crystal structure of HLA-B*07:02 with wild-type IDH2 peptide Heteromer
P48735; P61769;
PEG;1PE;SO4;PGE;26-300
Assess
KIR3DL1*005 in complex with HLA-B*57:01 Heteromer
P01834; P43629; P61769;
NAG;25-299
Assess
Human leukocyte antigen B*07:02 in complex with SARS-CoV2 epitope SPRWYFYYL Heteromer
P59595; P61769;
P6G;25-299
Assess
Crystal Structure of HLA-B*5701, presenting the self peptide, LSSPVTKSF Heteromer
P01834; P61769;
GOL;25-299
Assess
KIR3DL1*015 in complex with HLA-B*57:01 Heteromer
P01834; P43629; P61769;
NAG;25-299
Assess
Crystal structure of HLA-B*4103 in complex with a 16mer self-peptide derived from heterogeneous nuc… Heteromer
P07910; P61769;
ACT;25-298
Assess
Structures of Three HIV-1 HLA-B5703-Peptide Complexes and Identification of Related HLAs Potentiall… Heteromer
P61769; Q8URG0;
25-298
Assess
Crystal Structure of HLA-B5703 and HIV-1 peptide Heteromer
P61769; Q1KW74;
25-298
Assess
Crystal structure of HLA-b46 at 1.6 angstrom resolution Heteromer
P17763; P61769;
NA;25-298
Assess
TCR55 in complex with Pep20/HLA-B35 Heteromer
P61769;
27×GOL;PO4;27-300
Assess
An Nt-acetylated peptide complexed with HLA-B*3901 Heteromer
O00571; P61769;
25-298
Assess
Crystal structure of HLA-B*4104 in complex with a 11mer self-peptide derived from S-methyl-5-thioad… Heteromer
P61769; Q13126;
25-298
Assess
A peptide complexed with HLA-B*3901 Heteromer
O00571; P61769;
25-298
Assess
Structural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphi… Heteromer
P61769; Q70XD7;
25-298
Assess
A peptide complexed with HLA-B*3901 Heteromer
O00571; P61769;
25-298
Assess
Structural features underlying T-cell receptor sensitivity to concealed MHC class I micropolymorphi… Heteromer
P61769; Q70XD7;
25-298
Assess
Crystal structure of the KFJ37 TCR-NY-ESO-1-HLA-B*07:02 complex Heteromer
P61769; P78358;
25-298
Assess
The crystal structure of a self-peptide complexed to Abacavir and HLA-B*57:01 Heteromer
O00267; P61769;
1KX;26-298
Assess

1 Homology model

Oligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
monomer0.876at5.1.A25-299
100.00
Assess

Alignments